Stifel Nicolaus upgraded shares of Alkermes (NASDAQ:ALKS – Free Report) from a hold rating to a buy rating in a research note released on Tuesday, Marketbeat Ratings reports. The firm currently has ...

Among the posters, Alkermes presented results from a real-world, retrospective study of healthcare resource utilization (HCRU) and treatment patterns in patients with schizophrenia and patients with ...

Taking the first step to start addiction treatment is an uphill battle, but what can prove to be harder is keeping on a ...

Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price ...

In a report released on November 5, Marc Goodman from Leerink Partners maintained a Buy rating on Stoke Therapeutics (STOK – Research ...

StockNews.com upgraded shares of Advanced Energy Industries (NASDAQ:AEIS – Free Report) from a sell rating to a hold rating ...

Another Trump term could spur Europe’s efforts to stand on its own, but it is far from clear its leaders will seize the moment this time. By Steven Erlanger Beijing is expecting more ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...